Recent News

• 04.15.2025 - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
• 04.15.2025 - RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.12.2025 - Barclays 27th Annual Global Healthcare Conference
• 03.11.2025 - Leerink Global Healthcare Conference
• 03.11.2025 - Leerink Global Healthcare Conference
• 03.07.2025 - RAPT Therapeutics to Participate in Upcoming Investor Conferences
• 03.07.2025 - RAPT Therapeutics to Participate in Upcoming Investor Conferences
• 03.07.2025 - RAPT Therapeutics to Participate in Upcoming Investor Conferences
• 03.06.2025 - RAPT Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Recent Filings

• 04.04.2025 - PRE 14A Other preliminary proxy statements
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.27.2025 - 8-K Current report
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.06.2025 - 8-K Current report
• 03.06.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors